Trade AbbVie ABBV

Sell
 Buy

AbbVie live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

AbbVie News

Ghko B 2026 Jan 29, 16:00

Top AI computing stocks to watch: NVIDIA (NVDA), AMD stock, Broadcom (AVGO)

Frances Wang 2026 Jan 29, 16:00

Big tech stock analysis: Meta stocks jumped 10%, what’s going on with Meta?

Frances Wang 2026 Jan 29, 16:00

Retail stocks to watch 2026: Costco (COST) stock, AMZN, Walmart (WMT)

Ghko B 2026 Jan 29, 16:00

Ripple (XRP) price prediction: XRP slides after recent surges, what’s next?

Frances Wang 2026 Jan 29, 16:00

Silver prices hit record highs: What’s driving Silver (XAG/USD) price?

Ghko B 2026 Jan 29, 16:00

Microsoft stock crashes more than 10%: Is MSFT stock a good buy now?

Frances Wang 2026 Jan 29, 16:00

Stock market analysis: S&P 500 slipped 9.02 points, MSFT stock dropped 10%

Ghko B 2026 Jan 28, 16:00

Gold price prediction 2026: Will gold (XAU) touch new highs in coming days?

Ghko B 2026 Jan 28, 16:00

Gold rally continues: What’s the best platform to trade gold (XAU/USD)?

Ghko B 2026 Jan 28, 16:00

Best AI infrastructure stocks to buy: NVDA stock, AVGO, Micron (MU)

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

1.45

Spread (%)

0.6523 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

394144415744

Shares Outstanding

1767384632

Earnings Date (Next)

0000-00-00

Div Yield

2026-02-17

Ex-Dividend Date

2026-01-16

Forward annual dividend rate

6.65

Forward annual dividend yield

0.0302

EPS

1.34

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. AbbVie Inc. has strategic partnership with OSE Immunotherapeutics. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Jan 29, 16:00

CFD trading basics: Long position VS. short position, which is better?

Ghko B 2026 Jan 27, 16:00

What is a stochastic indicator: How to read the stochastic indicator?

Ghko B 2026 Jan 25, 16:00

CFD Trading Basics: Beginners Guide to Fundamental Analysis

Trustpilot